In summary, we have showed an increased frequency and suppressive activity of CD4+CD25+FoxP3+CD127lo Treg in PB, BM, and involved lymphatic tissues from patients with B-cell NHL, which might play a critical role in suppressing the host immune responses to tumor. This evidence concerns the gene FOXP3 and B-cell non-Hodgkin lymphoma.